Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C11H15ClN4O2 |
| Molecular Weight | 270.715 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN(CC1=CN=C(Cl)C=C1)C(\NC)=C\[N+]([O-])=O
InChI
InChIKey=CFRPSFYHXJZSBI-DHZHZOJOSA-N
InChI=1S/C11H15ClN4O2/c1-3-15(11(13-2)8-16(17)18)7-9-4-5-10(12)14-6-9/h4-6,8,13H,3,7H2,1-2H3/b11-8+
| Molecular Formula | C11H15ClN4O2 |
| Molecular Weight | 270.715 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
DescriptionSources: https://www.drugs.com/pro/capstar.htmlCurator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/12012747 | https://www.ncbi.nlm.nih.gov/pubmed/12208819 | https://www.ncbi.nlm.nih.gov/pubmed/12814666
Sources: https://www.drugs.com/pro/capstar.html
Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/12012747 | https://www.ncbi.nlm.nih.gov/pubmed/12208819 | https://www.ncbi.nlm.nih.gov/pubmed/12814666
Nitenpyram is a neonicotinoid, a neurotoxin that blocks neural messages and used in agriculture and veterinary medicine to kill external parasites of pets. Imidacloprid act as agonists at the insect nicotinic acetylcholine receptor (nAChR). The botanical insecticide nicotine acts at the same target without the neonicotinoid level of effectiveness or safety. Fundamental differences between the nAChRs of insects and mammals confer remarkable selectivity for the neonicotinoids. Whereas ionized nicotine binds at an anionic subsite in the mammalian nAChR, the negatively tipped ("magic" nitro or cyano) neonicotinoids interact with a proposed unique subsite consisting of cationic amino acid residue(s) in the insect nAChR. Nitenpyram was introduced into the United States in 1994 as a veterinary flea control treatment, structural pest and crop insecticide, and seed treatment. It has been used orally in dogs, cats, and some wildlife species for over 10 years. After ingestion, it begins killing adult fleas within 30 minutes, and effects continue for up to 48 hours. Though nitenpyram is used to kill adult fleas quickly on an infected animal, it does not kill insect eggs and has no long-term activity. Thus, it is not effective as a long-term flea preventative; however, it can be repeatedly applied over the course of several days to eradicate a single instance of infestation. Nitenpyram can be combined with a longer-term flea preventative like fipronil or lufenuron to prevent reinfestation. Neonicotinoids for veterinary use are considered to have a low order of toxicity for domestic animals and there are no reports of nitenpyram intoxication.
Originator
Sources: https://encrypted.google.com/patents/EP0392560B1
Curator's Comment: # Takeda Chemical Industries, Ltd
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL3350223 Sources: https://www.ncbi.nlm.nih.gov/pubmed/10936213 |
11.0 nM [IC50] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | capstar Approved UseUnknown |
Cmax
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
4327 ng/mL |
1 mg/kg single, oral dose: 1 mg/kg route of administration: Oral experiment type: SINGLE co-administered: |
NITENPYRAM plasma | Felis catus population: HEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
4327 ng/mL |
11.4 mg single, oral dose: 11.4 mg route of administration: Oral experiment type: SINGLE co-administered: |
NITENPYRAM plasma | Felis catus population: UNKNOWN age: ADULT sex: UNKNOWN food status: UNKNOWN |
AUC
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
39061 ng × h/mL |
1 mg/kg single, oral dose: 1 mg/kg route of administration: Oral experiment type: SINGLE co-administered: |
NITENPYRAM plasma | Felis catus population: HEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
T1/2
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
7.7 h |
11.4 mg single, oral dose: 11.4 mg route of administration: Oral experiment type: SINGLE co-administered: |
NITENPYRAM plasma | Felis catus population: UNKNOWN age: ADULT sex: UNKNOWN food status: UNKNOWN |
Overview
| CYP3A4 | CYP2C9 | CYP2D6 | hERG |
|---|---|---|---|
OverviewOther
| Other Inhibitor | Other Substrate | Other Inducer |
|---|---|---|
Drug as perpetrator
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
Page: 7.0 |
inconclusive [IC50 34.6713 uM] | |||
| no | ||||
Page: 52.0 |
no | |||
Page: 103.0 |
no | |||
Page: 103.0 |
no | |||
Page: 81.0 |
no | |||
Page: 100.0 |
no | |||
| no | ||||
| no | ||||
| no | ||||
| no | ||||
| no | ||||
| no | ||||
| no | ||||
| weak | ||||
| weak | ||||
| weak | ||||
| weak | ||||
| weak |
Drug as victim
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
Page: 80.0 |
inconclusive |
Tox targets
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
Page: 107.0 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Evaluating the insecticide resistance potential of eight Drosophila melanogaster cytochrome P450 genes by transgenic over-expression. | 2007-05 |
|
| Cis-regulatory elements in the Accord retrotransposon result in tissue-specific expression of the Drosophila melanogaster insecticide resistance gene Cyp6g1. | 2007-03 |
|
| Microarray analysis of cytochrome P450 mediated insecticide resistance in Drosophila. | 2003-07 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.drugs.com/pro/capstar.html
For dogs and cats -- 11.4-57mg/day
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12814666
Xenopus laevis oocytes were used for activity evaluation. Stock solutions of imidacloprid (1 mM), CH-IMI (10 mM), DN-IMI (10 mM) and nitenpyram (100 mM) in SOS were stored at 4 C. To suppress any possible endogenous muscarinic response, saline containing 0.5 M atropine was employed. Using two-electrode voltage-clamp electrophysiology, membrane currents were recorded by a GENECLAMP 500B (Axon Instruments, Union City, CA, USA) amplifier at a membrane potential of -100 mV. Current signals were displayed on a pen recorder. Oocytes were challenged with test compounds at intervals of 3–5 min to minimize effects of desensitization. Concentration-response data were obtained, not only by challenging oocytes with increasing concentrations of either ACh or neonicotinoid, but also by deploying decreasing concentrations of the compounds under test in order to confirm the validity of the concentration-response curve. The maximum amplitude of the current recorded in response to each challenge was normalized to the maximum amplitude of the current response to ACh
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:19:17 GMT 2025
by
admin
on
Mon Mar 31 18:19:17 GMT 2025
|
| Record UNII |
3A837VZ81Y
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C737
Created by
admin on Mon Mar 31 18:19:17 GMT 2025 , Edited by admin on Mon Mar 31 18:19:17 GMT 2025
|
||
|
WHO-VATC |
QP53BX02
Created by
admin on Mon Mar 31 18:19:17 GMT 2025 , Edited by admin on Mon Mar 31 18:19:17 GMT 2025
|
||
|
CFR |
21 CFR 520.1510
Created by
admin on Mon Mar 31 18:19:17 GMT 2025 , Edited by admin on Mon Mar 31 18:19:17 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C80604
Created by
admin on Mon Mar 31 18:19:17 GMT 2025 , Edited by admin on Mon Mar 31 18:19:17 GMT 2025
|
PRIMARY | |||
|
m7924
Created by
admin on Mon Mar 31 18:19:17 GMT 2025 , Edited by admin on Mon Mar 31 18:19:17 GMT 2025
|
PRIMARY | Merck Index | ||
|
nitenpyram
Created by
admin on Mon Mar 31 18:19:17 GMT 2025 , Edited by admin on Mon Mar 31 18:19:17 GMT 2025
|
PRIMARY | |||
|
C464843
Created by
admin on Mon Mar 31 18:19:17 GMT 2025 , Edited by admin on Mon Mar 31 18:19:17 GMT 2025
|
PRIMARY | |||
|
DTXSID8041080
Created by
admin on Mon Mar 31 18:19:17 GMT 2025 , Edited by admin on Mon Mar 31 18:19:17 GMT 2025
|
PRIMARY | |||
|
3034287
Created by
admin on Mon Mar 31 18:19:17 GMT 2025 , Edited by admin on Mon Mar 31 18:19:17 GMT 2025
|
PRIMARY | |||
|
341379
Created by
admin on Mon Mar 31 18:19:17 GMT 2025 , Edited by admin on Mon Mar 31 18:19:17 GMT 2025
|
PRIMARY | RxNorm | ||
|
300000023686
Created by
admin on Mon Mar 31 18:19:17 GMT 2025 , Edited by admin on Mon Mar 31 18:19:17 GMT 2025
|
PRIMARY | |||
|
3A837VZ81Y
Created by
admin on Mon Mar 31 18:19:17 GMT 2025 , Edited by admin on Mon Mar 31 18:19:17 GMT 2025
|
PRIMARY | |||
|
150824-47-8
Created by
admin on Mon Mar 31 18:19:17 GMT 2025 , Edited by admin on Mon Mar 31 18:19:17 GMT 2025
|
PRIMARY | |||
|
NITENPYRAM
Created by
admin on Mon Mar 31 18:19:17 GMT 2025 , Edited by admin on Mon Mar 31 18:19:17 GMT 2025
|
PRIMARY | |||
|
DB11438
Created by
admin on Mon Mar 31 18:19:17 GMT 2025 , Edited by admin on Mon Mar 31 18:19:17 GMT 2025
|
PRIMARY | |||
|
3A837VZ81Y
Created by
admin on Mon Mar 31 18:19:17 GMT 2025 , Edited by admin on Mon Mar 31 18:19:17 GMT 2025
|
PRIMARY | |||
|
39170
Created by
admin on Mon Mar 31 18:19:17 GMT 2025 , Edited by admin on Mon Mar 31 18:19:17 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |